|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OCCASIONAL PIECES |
1 Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitè di Verona, Italy
2 Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Italy
Correspondence to:
Professor G Lippi, MD, Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitè degli Studi di Verona, Ospedale Policlinico GB Rossi, Piazzale Scuro, 10, 37134 Verona, Italy; ulippi@tin.it
| The first 150 words of the full text of this article appear below. |
There is rather a long history of fraud in sport competitions, and doping has plagued the Tour de France almost since its beginning in 1903, culminating on 13 July, 1967 with the dramatic death of British cyclist Tom Simpson on the climb of Mont Ventoux, attributed to the use of amphetamines and complicated by the now defunct practice of drinking as little as possible.1 Nearly a year after the 2006 "Tour de Chaos", when nine riders who were implicated in an international doping probe based on blood transfusions were ruled out of the race and the winner of the yellow jersey tested positive for testosterone,2 a sequence of events again plagued the 2007 competition. First, a German rider was tested non-negative for testosterone in an out-of-competition antidoping control a few days before the start of the race. Then, an Italian rider tested "non-negative" in a doping test for testosterone after
This article has been cited by other articles:
![]() |
A. Pipe MD Dip Spo and P. C. Hebert MD MHSc Doping, sport and the community Can. Med. Assoc. J., August 12, 2008; 179(4): 303 - 303. [Full Text] [PDF] |
||||
![]() |
A. Pipe MD dip. m& and P. C. Hebert MD MHSc Le dopage, le sport et la communaute Can. Med. Assoc. J., August 12, 2008; 179(4): 305 - 305. [Full Text] [PDF] |
||||
![]() |
G. Lippi, M. Franchini, and G. C. Guidi Doping in competition or doping in sport? Br. Med. Bull., June 1, 2008; 86(1): 95 - 107. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |